A. Hoeflich et al., HUMAN COLON-CARCINOMA CELLS (CACO-2) SYNTHESIZE IGF-II AND EXPRESS IGF-I RECEPTORS AND IGF-II M6P RECEPTORS/, Molecular and cellular endocrinology, 101(1-2), 1994, pp. 141-150
The IGFs have been implicated in the development of the intestinal tra
ct. We have studied the human colon carcinoma cell line CaCo-2 to gain
more insight into the function of the IGFs in the gut. [I-125]IGF-I a
nd -II bound specifically to CaCo-2 cells as measured in competitive b
inding experiments. The existence of IGF-I receptors was further demon
strated by affinity crosslinking studies using DSS as the crosslinking
agent. Western blotting of CaCo-2 cell extracts using an anti IGF-II/
M6P receptor antiserum provided additional evidence for the expression
of the IGF-II/M6P receptor. In addition, Northern blotting experiment
s showed specific; IGF-I receptor and IGF-II/M6P receptor gene express
ion in CaCo-2 cells. An 11 kb band was visualized with a 614 bp PstI I
GF-I receptor probe on autoradiographs. Hybridization with a 663 bp IG
F-II/M6P receptor probe yielded a 9 kb RNA species. Analysis of CaCo-2
cell RNA using solution hybridization/RNase protection assays yielded
two protected fragments, approximately 379 bases in length, with a 39
4 base IGF-I receptor riboprobe and a 250 base protected fragment with
a 260 base IGF-II/MBP receptor riboprobe. In a subset of experiments
a PstI 700 base fragment of the IGF-I cDNA and a 554 base SalI fragmen
t of the IGF-II cDNA were used for hybridization: no hybridization was
detected with the IGF-I probe. However, using the [P-32]IGF-II probe
bands at 6.0 and 5.0 kb were labeled in Northern blotting experiments.
Analysis of CaCo-2 cell RNA using solution hybridization/RNase protec
tion assays yielded a 289 base protected fragment and a faint 534 base
species with a 556 base human IGF-II riboprobe. In addition, IGF-II i
mmunoreactivity was measured in CaCo-2 cell-conditioned medium using a
n IGF-binding protein blocked radioimmunoassay. CaCo-2 cell-conditione
d medium contained 5-15 ng/ml IGF-II immunoreactivity. In conclusion,
(1) CaCo-2 cells express both IGF-I receptor mRNA and IGF-II/M6P recep
tor mRNA and contain functional IGF-I receptor and IGF-II/M6P receptor
protein. (2) CaCo-2 cells express IGF-II mRNA and secrete IGF-II immu
noreactivity. We hypothesize that in human colon carcinoma cells IGF-I
I could act as an autocrine growth factor or alternatively could serve
as a regulatory factor during differentiation.